Pharmacometabolomics Informs About Pharmacokinetic Profile of Methylphenidate-Reference-Cited by-同舟云学术

Pharmacometabolomics Informs About Pharmacokinetic Profile of Methylphenidate

Published:2018-08 Issue:8 Volume:7 Page:525-533
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT Pharmacometrics Syst. Pharmacol.

Author:

Kaddurah-Daouk Rima¹²,Hankemeier Thomas³⁴,Scholl Elizabeth H.⁵,Baillie Rebecca⁶,Harms Amy³⁴,Stage Claus⁷,Dalhoff Kim P.⁷,Jűrgens Gesche⁸,Taboureau Olivier⁹,Nzabonimpa Grace S.¹⁰,Motsinger-Reif Alison A.¹¹⁵,Thomsen Ragnar¹²,Linnet Kristian¹²,Rasmussen Henrik B.¹³¹⁴, ,

Affiliation:

1. Duke Psychiatry and Behavioral Sciences; Duke University Medical Center; Durham North Carolina USA

2. Duke Institute for Brain Sciences, Duke University; Durham North Carolina USA

3. Division of Analytical Biosciences; Leiden Academic Centre for Drug Research; Leiden The Netherlands

4. Netherlands Metabolomics Centre; Leiden The Netherlands

5. Bioinformatics Research Center, North Carolina State University; Raleigh North Carolina USA

6. Rosa & Co LLC; San Carlos California USA

7. Department of Clinical Pharmacology; Bispebjerg and Frederiksberg University Hospital; Frederiksberg Denmark

8. Clinical Pharmacological Unit, Zealand University Hospital; Roskilde Denmark

9. INSERM, UMRS 973, MTi, Université Paris Diderot; Paris Cedex France

10. Center for Biological Sequence Analysis, Department of Systems Biology; Technical University of Denmark; Lyngby Denmark

11. Department of Statistics; North Carolina State University; Raleigh North Carolina USA

12. Section of Forensic Chemistry, Department of Forensic Medicine, Faculty of Health and Medical Sciences; University of Copenhagen; Denmark

13. Institute of Biological Psychiatry, Mental Health Centre Sct. Hans, Copenhagen University Hospital; Roskilde Denmark

14. Department of Science and Environment; Roskilde University; Roskilde Denmark

Funder

Danish Council for Strategic Research, Programme Commission on Individuals, Disease and Society

Publisher

Wiley

Subject

Pharmacology (medical),Modeling and Simulation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/psp4.12309/fullpdf

Reference39 articles.

1. Diagnosis and management of attention-deficit/hyperactivity disorder in children, young people, and adults: summary of NICE guidance;Kendall;BMJ,2008

2. A survey of medication treatment for hyperactive/inattentive students;Safer;JAMA,1988

3. Pharmacotherapy of attention-deficit/hyperactivity disorder: nonstimulant medication approaches;Mohammadi;Expert Rev. Neurother.,2007

4. An evaluation of the pharmacokinetics of methylphenidate for the treatment of attention-deficit/hyperactivity disorder;Frölich;Expert Opin. Drug Metab. Toxicol.,2014

5. Prediction of CYP2D6 phenotype from genotype across world populations;Gaedigk;Genet. Med.,2017

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding the side effects of chronic silodosin administration via untargeted metabolomics approach;Annales Pharmaceutiques Françaises;2024-08

2. Pharmacometabolomics of trabectedin in metastatic soft tissue sarcoma patients;Frontiers in Pharmacology;2023-08-11

3. A metabolomics study: Could plasma metabolites be a guide for the prevention of tamsulosin side effects?;Annales Pharmaceutiques Françaises;2023-03

4. Pharmacometabolomics-Based Translational Biomarkers: How to Navigate the Data Ocean;OMICS: A Journal of Integrative Biology;2022-10-01

5. Integrative systems analysis identifies genetic and dietary modulators of bile acid homeostasis;Cell Metabolism;2022-10